Breakingviews

Teva’s $40 bln hostile bid puts hope over reality

April 21, 2015

The Israeli drugmaker needs a deal to shore up falling sales. Smaller rival Mylan offers that and oodles of synergies. A tie-up, though, would face antitrust concerns, require high leverage and have to get around a powerful poison pill. No wonder the market is skeptical.

Egypt-Israel energy ties look broken

April 25, 2012

It is hard to believe that Egypt’s termination of a long-term contract to supply gas to Israel is a pure business dispute given the odd timing of the move. In the absence of a resolution Israel faces some difficult months. That’s bad for peace but doesn’t destroy it.

Iran, the day-after problem

September 30, 2009

The drums of war are beating in the Middle East. Proponents of a military strike against Iran’s nuclear facilities have intensified their campaign in recent weeks, arguing the military option is the only way to ensure the country does not build a nuclear weapon.